Abstract: The present invention relates to a topical composition comprising dimethylglycine and/or a salt of dimethylglycine and having a pH of 3.0 to 5.9. In addition, the present invention relates to the use (cosmetic and/or medicinal) of this composition for the treatment of hair and/or skin.

Abstract: The present invention relates to a composition containing dimethylglycine and/or a salt of dimethylglycine. In addition, the present invention relates to the use (cosmetic and/or medicinal) of this composition for the treatment of hair and scalp.

Abstract: The invention relates to a composition comprising hydroxyapatite for use in the treatment and/or prevention of a virus infection.

Abstract: The invention relates to the treatment of hair loss with minoxidil and caffeine.

Abstract: The invention relates to an oil-in-water emulsion containing 15.0 to 30.0 wt.-% ethanol.

Abstract: The present invention relates to the use of Ca5(PO4)3(OH) (hydroxyapatite; HAP) and a dental care composition comprising Ca5(PO4)3(OH) for the deep-layer remineralization of demineralized teeth, in particular for the deep-layer remineralization of demineralized dental enamel. Ca5(PO4)3(OH) used according to the invention and the dental care composition used according to the invention can be applied in the treatment and/or prevention of various diseases affecting the teeth, in particular caries.

Abstract: The present invention relates to an oil-in-water emulsion comprising a glycopyrronium salt and an emulsifier system comprising at least one macrogol glycerol fatty acid ester, at least one glycerol fatty acid ester and at least one fatty alcohol. Moreover, the present invention relates to such an emulsion for use as a medicament, in particular for treating and preventing diseases in conjunction with excessive sweating. In addition the present invention relates to the non-therapeutic use of such an oil-in-water emulsion for topical application on the skin of a mammal in order to reduce sweating.

Abstract: The present invention relates to a floor grinding apparatus (100) with a housing (110) having an interior space (111) open to one side, a carrier plate (120) rotatably mounted in the interior space (111) for receiving abrasives, and drive unit (130) adapted to rotate the carrier plate (120), the housing (110) having an inner dust sealing ring (112) with at least one recess (115), wherein the inner dust sealing ring (112) divides the interior space (111) into an inner portion (113) and an outer portion (114), and wherein the carrier plate (120) is disposed in the inner portion (114), at least one extraction opening (116) disposed in the outer portion (114), and an outer dust sealing ring (117) enclosing the interior space (111), the inner dust sealing ring (112) and the outer dust sealing ring (117) being arranged to define a common working plane parallel to the plane of rotation of the carrier plate (120).

Abstract: The present invention relates to tripeptide compounds according to the general formula (1) and their use as a medicament, in particular as anti-inflammatory agents.

Abstract: The present invention relates to a milling drum for removing glued-down floor coverings, in particular wooden floor coverings, preferably parquet floor coverings, in particular multilayer parquet, with a predetermined milling width which determines the width of a floor surface section by running the milling drum over the floor surface section to be machined, having a plurality of cutting plates which are arranged tangentially on the milling drum and which are arranged in a distributed manner on the milling drum, such that, upon a complete revolution of the milling drum, the entire milling width is operable with at least one cutting plate and such that a common width of the cutting plates being in contact simultaneously with the floor surface section to be machined is always smaller than the milling width.

Abstract: The present invention relates to pharmaceutical and cosmetic formulations containing an extract of Echinacea and linoleic acid derivatives, particularly emulsions containing an extract of Echinacea and linoleic acid derivatives as an active agent combination, and the use of such formulations as medicines, medicinal products and/or cosmetics.

Abstract: The invention relates to Lysyl-Prolyl-Threonine lyophilized formulations, in particular to L-Lysyl-D-Prolyl-L-Threonine lyophilized formulations, that are stable in storage, and to a process for preparing the lyophilized formulations. Moreover, the invention relates to pharmaceutical and cosmetic compositions comprising the lyophilized formulations, that are used in the therapeutic and/or prophylactic treatment, diagnosis and/or therapy of pain-related diseases, pruritus-related diseases, inflammatory diseases, and/or other diseases in a mammal.

Abstract: The present invention relates to a floor grinding apparatus (100) with a housing (110) having an interior space (111) open to one side, a carrier plate (120) rotatably mounted in the interior space (111) for receiving abrasives, and drive unit (130) adapted to rotate the carrier plate (120), the housing (110) having an inner dust sealing ring (112) with at least one recess (115), wherein the inner dust sealing ring (112) divides the interior space (111) into an inner portion (113) and an outer portion (114), and wherein the carrier plate (120) is disposed in the inner portion (114), at least one extraction opening (116) disposed in the outer portion (114), and an outer dust sealing ring (117) enclosing the interior space (111), the inner dust sealing ring (112) and the outer dust sealing ring (117) being arranged to define a common working plane parallel to the plane of rotation of the carrier plate (120).

Abstract: The present invention relates to tripeptide compounds according to the general formula (1) and their use as a medicament, in particular as anti-inflammatory agents.

Abstract: The use of eprotirome in the prevention and/or treatment of hair disorders is herein disclosed.

Abstract: The present invention relates to perhydroquinoxaline compounds according to the general formula (1), their use as a medicament, in particular as analgesic, antipruritic and anti-inflammatory agents, and their preparation.

Abstract: The present invention relates to a novel class of 1,3-benzoxazol-2(3H)-ones and their use as a medicament, preferably as a dermatologic agent, and as a cosmetic. These novel compounds are particularly useful in treating and/or preventing inflammation, irritation, itching, pruritus, pain, oedema and/or pro-allergic or allergic conditions in a patient. Usually they are topically applied to the skin or mucosa in the form of a pharmaceutical or cosmetic composition comprising the compound and a pharmaceutically and/or cosmetically acceptable carrier.

Abstract: The use of eprotirome in the prevention and/or treatment of hair disorders is herein disclosed.

Abstract: The invention relates to amphotheric surfactants for use in preventing and/or treating vaginal infections, in particular for preventing and treating pathogenic vaginal biofilms in vaginal infections, as well as to pharmaceutical compositions containing the amphoteric surfactants as active ingredients.

Abstract: The present invention relates to a novel class of 1,3-benzoxazol-2(3H)-ones and their use as a medicament, preferably as a dermatologic agent, and as a cosmetic. These novel compounds are particularly useful in treating and/or preventing inflammation, irritation, itching, pruritus, pain, oedema and/or pro-allergic or allergic conditions in a patient. Usually they are topically applied to the skin or mucosa in the form of a pharmaceutical or cosmetic composition comprising the compound and a pharmaceutically and/or cosmetically acceptable carrier.